Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rawlins may sit again in NICE chair

This article was originally published in Scrip

Executive Summary

The UK's Commissioner for Public Appointments has agreed an exemption that would allow Professor Sir Michael Rawlins to apply for another term as chairman of the National Institute for health and Clinical ExcellencehHwhen his current term ends on March 31st. He has held the position for 10 years, which is the maximum normally allowed under the code of practice for public appointments. NICE says that Sir Mike would have to reapply through an open, competitive recruitment process. The chairman is expected to devote up to three days per week to the job during a term of up to four years at an annual salary in the range £46,588-£62,117. Sir Mike's intentions have not been made public. NICE is also recruiting three non-executive directors for its board: Frederick George will be coming to the end of his three terms; Professor Shah Ebrahim is standing down; and Mercy Jeyasingham has come to the end of her second term.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC007537

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel